---
title: "DiGA in Orthopedics Facilitates Access to Innovative Treatments"
language: "en"
type: "post"
original_url: "https://www.atlas-digitale-gesundheitswirtschaft.de/en/blog/2025/03/18/diga-in-orthopedics-facilitates-access-to-innovative-treatments/"
human_version: "../../../../../../1/en/blog/2025/03/18/diga-in-orthopedics-facilitates-access-to-innovative-treatments/"
date: "2025-03-18"
section: "Hub-Article"
categories: ["Apps"]
reading_time: "10 Min."
description: "Digital health applications in orthopedics improve diagnostics, therapy, and patient care with AI-driven solutions."
publisher: "Lehrstuhl für Management und Innovation im Gesundheitswesen, Universität Witten/Herdecke"
---

# DiGA in Orthopedics Facilitates Access to Innovative Treatments

*March 18, 2025 · Hub-Article*

Hub-Article

## North Rhine-Westphalia combines expertise from practice, research and development

Digital health applications (DiGA) in orthopedics open up new possibilities for supporting diagnostics, therapy and follow-up care. They offer innovative approaches to support patients in a targeted manner, be it through personalized training programs, pain management apps or digital rehabilitation solutions. The focus is on promoting mobility, improving quality of life and reducing pain. Through the use of artificial intelligence and data-driven technologies, DiGA in orthopedics can also help optimize treatment outcomes and strengthen preventive measures. However, integrating such applications into everyday clinical practice also places new demands on the networking of patients, physicians, and therapists, while regulatory and privacy issues must be carefully considered.

For the Digital Health Applications Technology Hub, we spoke with three experts to explore the opportunities and challenges of DiGA in orthopedics and beyond. [Ronald Gräfe](https://www.linkedin.com/in/ronaldgraefe/) is a senior advisor for digital transformation in healthcare, helping organizations leverage technology to build patient-centric digital health ecosystems. His focus is on driving platform engagement through patient experience, generating new revenue streams with disruptive business models, and fostering partnerships. He joined [Kaia Health](https://kaiahealth.com/) in 2022 as Director of Patient and Provider Services. [Prof. Dr. Christoph Baltin](https://mvz.uk-koeln.de/fachbereiche/orthopaedie/team/) is a physician in private practice for orthopedics, trauma surgery and sports medicine. Since 2011, he has also worked at the [University Hospital of Cologne](https://www.uk-koeln.de/) in various capacities. During his career, he gained experience in the USA at the [Massachusetts General Hospital](https://www.massgeneral.org/) at [Harvard Medical School](https://hms.harvard.edu/) in Boston. Timo Neunaber works as a research assistant at the [Chair of Health Informatics](https://www.uni-wh.de/euer-campus/fakultaet-fuer-gesundheit/department-fuer-humanmedizin/lehrstuhl-fuer-gesundheitsinformatik) at the [University of Witten/Herdecke](https://www.uni-wh.de/) and as a consultant for digital health at [vdek – Verband der Ersatzkassen](https://www.vdek.com/). He conducts research at the interface between digital solutions for everyday health care and user acceptance and engagement.

### **What excites you about DiGA in orthopedics?**

**Ronald Gräfe:** For me, DiGAs are an ideal support for patients in therapy. Inpatient treatment is very expensive, and outpatient therapy services, where they exist, have their shortcomings. Many diseases do not require inpatient or outpatient treatment – they can often be treated at home. DiGAs play a crucial role here, adapting to the individual needs of patients and their daily routines. This allows patients to determine the pace and intensity of their therapy. Another major advantage is that DiGAs are evidence-based. They often build on established guidelines and bring them directly into the home environment. This supports the healthcare system by providing flexible, personalized and readily available therapy that is also effective and cost-saving. The therapy can then be discussed with the prescribing doctors and a further treatment plan can be developed.

**Prof. Dr. Christoph Baltin:** DIGAs are in tune with the times. Due to the ubiquity of smartphones, their use is literally within reach, which makes digital health applications extremely practical. They enable location-independent care, which is also an advantage for people in remote areas or with limited mobility. In the orthopedic field, for example, this makes it easy to integrate additional rehabilitation exercises to supplement existing physiotherapy. The patient’s convalescence can thus be professionally supported and ideally accelerated.

**Timo Neunaber:** For me, digital health applications are an important building block for improving patient care with digital applications. However, they should be integrated even more into existing care processes in order to increase acceptance and the tangible added value of the applications for patients and doctors. In addition, the positive effect on care should be proven before a DiGA is used. A good third of the DiGAs currently approved for trials have not yet been conclusively proven to provide actual added value.

### **Which DiGAs do you develop, use or prescribe in your organization?**

**Ronald Gräfe:** We have developed a DiGA that deals with non-specific back pain – a widespread disease that has increased significantly due to factors such as too much sitting, especially since the coronavirus pandemic and increased working in home offices. Back pain is often a lifestyle-related condition, triggered by too less exercise, lack of sleep or unhealthy habits. Our DiGA Kaia Back Pain offers a quickly accessible digital therapy that reaches many sufferers. In our Rise-uP study with 1,245 participants over 12 months, we showed that it not only improves patients’ quality of life, but also saves costs for the healthcare system and employers.

**Prof. Dr. Christoph Baltin:** In the orthopedic and trauma surgery sector, there are currently several digital health applications that have been permanently accepted as DIGA. Vivira for back, hip and knee pain and Companion Patella from Medi for knee pain have proven to be very helpful from our own experience. DIGA Kaia can help with the treatment of back pain and DIGA Orthopy also enables the integration of therapy sessions recommended by the physiotherapist treating the patient, which should be continued at home.

**Timo Neunaber:** Research into DiGA continues to be exciting from a scientific perspective. Even though there are already a number of studies on DiGA, further research is required. For example, the costs and economic benefits of the applications need to be investigated. There is still a lack of evidence that DiGA can save costs. Such studies are particularly relevant for the statutory health insurance funds as cost bearers. Due to the increasing spread of DiGA abroad, comparisons should also be made in future between the different designs of DiGA systems in order to learn from each other.

### **How can patients use DiGA effectively?**

**Ronald Gräfe:**The use of DiGA is particularly flexible, as the therapy can be carried out anywhere and at any time – be it in the evening at home or in between everyday activities. DiGA adapts to the patient’s rhythm of life and bridges the gaps that can occur with purely outpatient therapy, such as physiotherapy. While patients are often left to their own devices during a few physiotherapy sessions, DiGA offers continuous support: as in the case of Kaia’s back pain, it provides targeted guidance on exercises, ensures that they are performed correctly in real time by the AI-supported movement coach and also provides helpful knowledge units, breathing exercises and health status documentation for progress reviews. At the end, there is a progress report that can be used, for example, to discuss the therapy and for further therapy planning with those treating the patient.

**Prof. Dr. Christoph Baltin:** There are various areas of application for DIGAs, depending on the underlying cause of the complaint and the indication. It is important that DIGAs are used as a supplement to medical treatment, e.g. to support the rehabilitation process or reduce pain. Other areas of application can also be seen in basic prevention and health promotion or in supporting patients’ self-management. They should be targeted and coordinated with other therapy modalities in order to ensure the patient’s motivation for continuous use.

**Timo Neunaber:** The fields of application of DiGA vary depending on the disease. Currently, DiGAs are mainly used by patients without regular medical contact. In certain constellations, this may be appropriate, e.g. as support until psychotherapy is initiated. However, the manageable number of prescriptions shows that the acceptance and tangible added value of the applications for patients and doctors has so far been rather low. DiGA should therefore be better integrated into existing treatment processes in the future and lead to a noticeable improvement in care.

### **What risks should be considered when using DiGA in orthopedics?**

**Ronald Gräfe:** Indications and contraindications must be taken into account when using DiGA. It is important to distinguish between absolute and relative contraindications. An example from our DiGA for back pain: The recommended age is between 18 and 65 years. However, age is a relative contraindication, as physically fit patients over 65 can also benefit from the therapy. Another risk lies in the correct execution of the exercises. With our DiGA, this risk is minimized by AI-supported movement feedback in real time. The DiGA therefore provides support for exercises at home, which significantly reduces side effects due to incorrect execution compared to exercises performed independently.

**Prof. Dr. Christoph Baltin:** If there are certain contraindications, DIGAs are not allowed to be used. These include, for example, infections or some oncological diseases, e.g. when treating musculoskeletal complaints. In general, DIGAs must be approved for indication-specific treatment and adequate data protection must be ensured. If DIGAs are too complicated or are not user-friendly enough, patients are almost guaranteed to discontinue treatment quickly. Individual adaptation to the capabilities of the individual patient is very important in order to avoid overloading patients or causing collateral damage with standardized exercise programs. This is particularly necessary in the case of complex clinical pictures, such as multiple injuries with acute and chronic complaints. Incorrect execution, overestimation, physical limitations of older patients or technical difficulties are further risks that must be taken into account when using DIGAs.

**Timo Neunaber:** There are various risks associated with the use of DiGA, but these can be minimized. On the one hand, contraindications and other exclusion criteria must be ruled out when prescribing or applying for approval from the health insurance companies. This is relevant as some DiGA vendors enable the application for a DiGA by filling out a questionnaire without direct physician contact. The risks associated with DiGA are insufficiently excluded here. Further risks exist in the case of inadequate data protection and data security. In this respect, requirements for the approval of DiGA must be strictly examined to ensure that patient data is secure. Finally, the risk of DiGA is also increased by the medical devices of risk class IIb, which were made possible by the legislator with the Act to Accelerate the Digitalization of the Healthcare System (Digital Act). If approval is to remain with the Federal Institute for Drugs and Medical Devices in the fast-track procedure, such applications must be strictly examined. It is also correct that the legislator has excluded a trial phase for such applications.

### **What impact does DiGA have on the labor market?**

**Ronald Gräfe:** DiGAs enable digital therapies that can work without physical therapists and therefore serve as an important addition to existing structures. Especially in rural regions or underserved urban areas, DiGAs help to provide effective therapies. A wide range of profiles are required for DiGA manufacturers, which could lead to a growing number of providers and products, resulting in a stronger SME sector.

**Prof. Dr. Christoph Baltin:** The introduction of digital health applications has far-reaching effects on the healthcare market. On the one hand, competencies are being shifted to patients, who are thus becoming even more active players in the treatment of their complaints. At the same time, they relieve the workload of physicians and therapists and contribute to interdisciplinary cooperation. Digital media provide extensive support for the documentation and evaluation of patient data and objectify the progress of treatment, which can further relieve the burden on medical/therapeutic staff. On the other hand, DIGAs lead to changes in the range of tasks performed by physiotherapists, nursing staff and doctors. For example, previous documentation tasks such as movement recording and pain protocols can be automated, giving physiotherapists more time to treat more complex cases. Other effects on the labor market include the creation of new jobs. After all, DIGAs have to be developed and programmed, which requires an exchange of medical and therapeutic expertise. Approval for DIGA is linked to numerous requirements, and the marketing and continuous improvement of digital applications also leads to a resulting demand for labor.

**Timo Neunaber:** In principle, we can see that DiGAs are associated with changes in skills, for example for people involved in care such as physicians. For the prescription or general use of DiGA in everyday practice, healthcare professionals must acquire knowledge on the use of DiGA. Digital skills are therefore becoming increasingly important. Physicians play a relevant role in the dissemination of DiGA. Thus, general practitioners are usually still the first point of contact in the provision of care. In order to strengthen their knowledge of DiGAs, the use of digital solutions should be part of medical training.

### **How can patient acceptance and knowledge of DiGA be increased?**

**Ronald Gräfe:** Only a small proportion of the population is currently aware of DiGAs. Even among medical colleagues, knowledge about DiGA is still limited, which is often due to priorities in the implementation of other digital measures. Addressing patients is a crucial point: Doctors should prescribe DiGAs as a valuable and special therapy option. Patients should feel that they have to “earn” the use of a DiGA, which can increase motivation. In addition, the current redemption processes are an obstacle. Applying through health insurance companies, often with a waiting time of several days due to the mostly paper-based process, significantly delays the start of therapy. Digital therapies must be able to start as soon as the patient leaves the practice in order to increase their acceptance and effectiveness.

**Prof. Dr. Christoph Baltin:** The level of awareness of this therapy should be further increased. The benefits and added value can be made clearer to both patients and medical and therapeutic staff through greater transparency. Aspects such as user-friendliness and accessibility with patient-specific adaptation and flexibility should be clearly in the spotlight. The opportunities to objectify progress in treatment, for example through visualizations, or to further increase patient motivation through gamification approaches should certainly also be mentioned as promoting acceptance. The quality and safety of this product has been verified by the BfArM through recognition as a DIGA – health insurance companies can therefore reimburse it and make it available to more patients in the future.

**Timo Neunaber:** From my point of view, many different adjustments need to be made in order to increase patient acceptance and knowledge of DiGA. The most important thing is to increase patients’ digital health literacy. They must be empowered to understand, use and trust DiGAs. To this end, people who have had little contact with digital solutions to date must also be included. Otherwise, the digital divide will continue to widen. In this respect, projects to promote digital health literacy for vulnerable groups of people should also be initiated. The promotion of digital health literacy should be seen as a task for society as a whole. In addition to patients, all stakeholders involved in healthcare must also be included, for example.

### **Further information on the topic**

The ATLAS contains more articles and scientific abstracts on DiGA in orthopedics and other specialties.

- **Unutilised potential: Expert opinions on optimising DiGA access in Germany:**[https://www.atlas-digitale-gesundheitswirtschaft.de/blog/2023/12/05/optimierung-des-diga-zugangs/](../../../../../blog/2023/12/05/optimierung-des-diga-zugangs.md)
- **Characteristics of successful health apps: An international study develops an evaluation framework:** [https://www.atlas-digitale-gesundheitswirtschaft.de/blog/2023/12/05/merkmale-erfolgreicher-gesundheits-apps/](../../../../../blog/2023/12/05/merkmale-erfolgreicher-gesundheits-apps.md)
- **Regulation and Evaluation of Medical Apps: Alternatives Needed?**: [https://www.atlas-digitale-gesundheitswirtschaft.de/en/blog/2025/02/27/regulation-and-evaluation-of-medical-apps-alternatives-needed-2/](../../02/27/regulation-and-evaluation-of-medical-apps-alternatives-needed-2.md)


**Categories:** Apps

## Images on this page

- shutterstock_602386907.png: ../../../../../../1/assets/bilder/wp-content/uploads/2022/12/shutterstock_602386907.png

---
This page is optimised for AI systems. Human-readable version: [DiGA in Orthopedics Facilitates Access to Innovative Treatments](../../../../../../1/en/blog/2025/03/18/diga-in-orthopedics-facilitates-access-to-innovative-treatments/)
